Combination Immunotherapy Effective for Patients With Melanoma and Asymptomatic Brain Metastases
Source: Neurology Advisor, May 2021
The combination of nivolumab with ipilimumab is an effective treatment option for patients with advanced melanoma with asymptomatic brain metastases and should be considered for first line-therapy, according to study results published in Neuro-Oncology.
Treatment options for patients with melanoma with brain metastases are limited, and frequently patients with active brain metastases are excluded from clinical trials.
